tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IDYA Stock Latest News

Ideaya Biosciences Advances IDE849 Study for DLL3-Expressing Tumors
Company AnnouncementsIdeaya Biosciences Advances IDE849 Study for DLL3-Expressing Tumors
4d ago
IDYA
Promising Developments in IDEAYA Biosciences’ Pipeline Drive Buy Rating with $74 Price Target by 2026
PremiumRatings
Promising Developments in IDEAYA Biosciences’ Pipeline Drive Buy Rating with $74 Price Target by 2026
5d ago
IDYA
JPMorgan places ‘Positive Catalyst Watch’ on Ideaya into updates
PremiumThe Fly
JPMorgan places ‘Positive Catalyst Watch’ on Ideaya into updates
5d ago
IDYA
Ideaya Biosciences initiated with a Buy at Guggenheim
PremiumThe Fly
Ideaya Biosciences initiated with a Buy at Guggenheim
12d ago
IDYA
Ideaya Biosciences initiated with a Buy at Guggenheim
PremiumThe Fly
Ideaya Biosciences initiated with a Buy at Guggenheim
12d ago
IDYA
Ideaya Biosciences price target raised to $44 from $43 at Mizuho
PremiumThe FlyIdeaya Biosciences price target raised to $44 from $43 at Mizuho
18d ago
IDYA
IDEAYA Biosciences: Promising Clinical Developments and Strategic Positioning Highlighted by Buy Rating
Premium
Ratings
IDEAYA Biosciences: Promising Clinical Developments and Strategic Positioning Highlighted by Buy Rating
18d ago
IDYA
Ideaya Biosciences price target raised to $38 from $36 at RBC Capital
Premium
The Fly
Ideaya Biosciences price target raised to $38 from $36 at RBC Capital
21d ago
IDYA
Promising Pipeline and Competitive Edge: IDEAYA Biosciences Receives Buy Rating from Analyst
PremiumRatings
Promising Pipeline and Competitive Edge: IDEAYA Biosciences Receives Buy Rating from Analyst
21d ago
IDYA
Ideaya should be bought on yesterday’s selloff, says Wells Fargo
PremiumThe Fly
Ideaya should be bought on yesterday’s selloff, says Wells Fargo
21d ago
IDYA
Ideaya Biosciences selloff on R&D day overdone, says Citi
PremiumThe Fly
Ideaya Biosciences selloff on R&D day overdone, says Citi
21d ago
IDYA
IDEAYA Biosciences: Promising Pipeline and Clinical Advancements Drive Buy Rating
PremiumRatings
IDEAYA Biosciences: Promising Pipeline and Clinical Advancements Drive Buy Rating
21d ago
IDYA
Ideaya Biosciences price target lowered to $36 from $37 at Oppenheimer
PremiumThe FlyIdeaya Biosciences price target lowered to $36 from $37 at Oppenheimer
21d ago
IDYA
Ideaya Biosciences to present initial data from Phase 1/2 trial of IDE397
Premium
The Fly
Ideaya Biosciences to present initial data from Phase 1/2 trial of IDE397
22d ago
IDYA
IDEAYA Biosciences: Strong Buy Rating Backed by Promising Oncology Pipeline and Positive Phase 1 Data for IDE849
Premium
Ratings
IDEAYA Biosciences: Strong Buy Rating Backed by Promising Oncology Pipeline and Positive Phase 1 Data for IDE849
22d ago
IDYA
IDEAYA Biosciences Reports Promising Phase 1 Data for IDE849
PremiumCompany Announcements
IDEAYA Biosciences Reports Promising Phase 1 Data for IDE849
22d ago
8K
IDYA
Ideaya Biosciences to present OptimUM-09 trial data of darovasertib
PremiumThe Fly
Ideaya Biosciences to present OptimUM-09 trial data of darovasertib
22d ago
IDYA
Ideaya Biosciences price target raised to $45 from $41 at Citizens JMP
PremiumThe Fly
Ideaya Biosciences price target raised to $45 from $41 at Citizens JMP
22d ago
IDYA
Ideaya Biosciences Advances in Metastatic Uveal Melanoma Treatment Study
PremiumCompany Announcements
Ideaya Biosciences Advances in Metastatic Uveal Melanoma Treatment Study
22d ago
IDYA
Ideaya, Hengrui Pharma presented initial data from Phase 1 IDE849 trial
PremiumThe FlyIdeaya, Hengrui Pharma presented initial data from Phase 1 IDE849 trial
22d ago
IDYA
Ideaya Biosciences enrolls first patient in IDE397 trial
Premium
The Fly
Ideaya Biosciences enrolls first patient in IDE397 trial
26d ago
GILD
IDYA
Ideaya Biosciences initiated with an Outperform at Citizens JMP
Premium
The Fly
Ideaya Biosciences initiated with an Outperform at Citizens JMP
26d ago
IDYA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >